Incepta Pharmaceuticals Limited launched an anti-diabetic medication named "Orsema".
The injectable semaglutide medicine has been introduced in Bangladesh under the theme "Ensuring universal diabetes treatment" – commemorating this year's "World Diabetes Day", said a press release.
According to the press release, a weekly dose of
"Orsema" will manage blood glucose levels among diabetic patients.The
pre-filled syringe will be available in the market in two doses— 0.25mg
priced and 0.50mg.
A great company to deal with, extremely reliable with a good range of products. Excellent product knowledge, great communication & customer service, fair prices and fast delivery.